Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRISTINE: Etanercept Dosing in Psoriasis
NCT00663052Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jun 2008
- Primary completion
- Jan 2010
- Modality
- Fc-Fusion Proteins
- Countries
- 13
01
Overview
A Phase 4 trial of etanercept in plaque psoriasis, sponsored by Pfizer. Started Jun 2008; status: completed.
02
Drugs
etanercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00663052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00663052.